Business & Regulation

How to use a knowledge repository that doesn’t retire or leave you for a competitor.

Will FDA fast review and voucher incentives make a difference?

Amgen accuses Sandoz of snubbing its advances in a complex biosimilar dispute

Can phage endolysins revolutionize the way bacterial infections are treated – and prevent drug resistance?

The 2014 Access to Medicine index shows progress – but companies remain “conservative”

The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...

Organizations all over the globe are taking action against drug resistance.

Quick fire Q&A with Hans-Georg Eichler, Senior Medical Officer, EMA

Patients and physicians are tweeting, snapchatting, pinning and posting about healthcare, – some are making the leap into the digital world.

In a world of regulatory rigor and complex supply chains, product recalls are becoming increasingly challenging.